Literature DB >> 28398998

Pediatric Treatment Scale-Up: The Unfinished Agenda of the Global Plan.

Martina Penazzato1, Anouk Amzel, Elaine J Abrams, Karusa Kiragu, Shaffiq Essajee, Irene Mukui, Peter Elyanu, Anath A Rwebembera, Dorothy Mbori-Ngacha.   

Abstract

Five million children have died of AIDS-related causes since the beginning of the epidemic. In 2011, the Global Plan Towards the Elimination of New HIV Infections Among Children by 2015 and Keeping Their Mothers Alive (Global Plan) created the political environment to catalyze both the resources and commitment to end pediatric AIDS. Implementation and scale-up have encountered substantial hurdles, however, which have resulted in slow progress. Reasons include a lack of emphasis on testing outside of prevention of mother-to-child transmission services, an overall lack of integration and coordination with other services, a lack of training among providers, low confidence in caring for children living with HIV, and a lack of appropriate formulations for pediatric antiretrovirals. During the Global Plan period, we have learned that simplification is essential to successful decentralization, integration, and task shifting of services; that innovations require careful planning; and that the family is an important unit for delivering HIV care and treatment services. The post-Global Plan phase presents a number of noteworthy challenges that all stakeholders, national programs, and communities must tackle to guarantee universal treatment for children living with HIV. Accelerated action is essential in ensuring that HIV diagnosis and linkage to treatment happen as quickly and effectively as possible. As fewer infants are infected because of effective prevention of mother-to-child transmission interventions and the population of children living with HIV will age into adolescence adapting service delivery models to the epidemic context, and engaging the community will be critical to finding new efficiencies and allowing us to realize a true HIV-free generation-and to end AIDS by 2030.

Entities:  

Mesh:

Year:  2017        PMID: 28398998     DOI: 10.1097/QAI.0000000000001333

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  9 in total

1.  Temporal changes in paediatric and adolescent HIV outcomes across the care continuum in Zambia: an interrupted time-series analysis.

Authors:  Carolyn Bolton-Moore; Izukanji Sikazwe; Mwangelwa Mubiana-Mbewe; Gloria Munthali; Mwanza Wa Mwanza; Theodora Savory; Lugano Nkhoma; Paul Somwe; Angella Sandra Namwase; Elvin H Geng; Aaloke Mody
Journal:  Lancet HIV       Date:  2022-08       Impact factor: 16.070

Review 2.  Pathogenesis of Non-Zika Congenital Viral Infections.

Authors:  Suresh B Boppana; William J Britt; Karen Fowler; S Cecelia Hutto; Scott H James; David W Kimberlin; Claudette Poole; Shannon A Ross; Richard J Whitley
Journal:  J Infect Dis       Date:  2017-12-16       Impact factor: 5.226

3.  Pathways of care for HIV infected children in Beira, Mozambique: pre-post intervention study to assess impact of task shifting.

Authors:  Claudia Marotta; Carlo Giaquinto; Francesco Di Gennaro; Kajal D Chhaganlal; Annalisa Saracino; Jorge Moiane; Guido Maringhini; Damiano Pizzol; Giovanni Putoto; Laura Monno; Alessandra Casuccio; Francesco Vitale; Walter Mazzucco
Journal:  BMC Public Health       Date:  2018-06-07       Impact factor: 3.295

4.  "How Do We Start? And How Will They React?" Disclosing to Young People with Perinatally Acquired HIV in Uganda.

Authors:  Stella Namukwaya; Sara Paparini; Janet Seeley; Sarah Bernays
Journal:  Front Public Health       Date:  2017-12-13

5.  Assessing the adoption of lopinavir/ritonavir oral pellets for HIV-positive children in Zimbabwe.

Authors:  Briony Pasipanodya; Rudo Kuwengwa; Margaret L Prust; Bethany Stewart; Christine Chakanyuka; Tonderayi Murimwa; Jason Brophy; Olawale Salami; Angela Mushavi; Tsitsi Apollo
Journal:  J Int AIDS Soc       Date:  2018-12       Impact factor: 5.396

6.  Home- and Clinic-Based Pediatric HIV Index Case Testing in Kenya: Uptake, HIV Prevalence, Linkage to Care, and Missed Opportunities.

Authors:  Cyrus Mugo; Jiayu Wang; Emily R Begnel; Irene N Njuguna; Elizabeth Maleche-Obimbo; Irene Inwani; Jennifer A Slyker; Grace John-Stewart; Dalton C Wamalwa; Anjuli D Wagner
Journal:  J Acquir Immune Defic Syndr       Date:  2020-12-15       Impact factor: 3.771

7.  Setting Global Research Priorities in Pediatric and Adolescent HIV Using the Child Health and Nutrition Research Initiative (CHNRI) Methodology.

Authors:  Cadi Irvine; Alice Armstrong; Jason M Nagata; Nigel Rollins; Diddie Schaaf; Meg Doherty; Martina Penazzato; Marissa Vicari
Journal:  J Acquir Immune Defic Syndr       Date:  2018-08-15       Impact factor: 3.731

8.  Propelling the Pediatric HIV Therapeutic Agenda With Science, Innovation, and Collaboration.

Authors:  Elaine J Abrams; Jintanat Ananworanich; Moherndran Archary; McNeil Ngongondo; Pim Brouwers
Journal:  J Acquir Immune Defic Syndr       Date:  2018-08-15       Impact factor: 3.731

9.  Perceived Barriers Toward Provider-Initiated HIV Testing and Counseling (PITC) in Pediatric Clinics: A Qualitative Study Involving Two Regional Hospitals in Dar-Es-Salaam, Tanzania.

Authors:  Rose Marwa; Amani Anaeli
Journal:  HIV AIDS (Auckl)       Date:  2020-03-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.